Research: Stereotactic Body Radiation Therapy for Lung Cancer

When investigating different lung cancer treatment options for you or a loved one, clinical research can help you understand long-term effects and outcomes for lung cancer patients. Below is an overview of the latest research, highlighting efficacy of stereotactic body radiation therapy (SBRT) for lung cancer:

  • Virginia Hospital Center and Georgetown University Hospital shared results showing that combining SBRT with other forms of treatment for non-small cell lung cancer can improve survival outcomes. Read more here.
  • Data collected by The German Society of Radiation Oncology showed that of 600 non-small cell lung cancer patients who underwent SBRT, low rates of the spread of their tumors were consistently found thanks in large part to the radiotherapy dosage. Find more details on the study from the International Association for the Study of Lung Cancer.
  • In a study completed by members of the Japan Clinical Oncology Group (JCOG), researchers examined the safety and efficacy of SBRT for 100 lung cancer patients treated over four years. Results show that patients exhibited minimal toxicity and overall survival rates doubled as compared to conventional radiation treatment. Read more at the Radiological Society of North America.

To learn more about SBRT and its advantages for lung cancer patients, feel free to contact us.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.